Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?

Tuberous sclerosis complex (TSC) is an autosomal dominant and multi-system genetic disorder in humans. TSC affects around 25,000 to 40,000 individuals in the United States and about 1 to 2 million individuals worldwide, with an estimated prevalence of one in 6,000 newborns. TSC occurs in all races a...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Samy L, Al-Obaidi, Noor Y, Nowacki, Maciej, Pietkun, Katarzyna, Zegarska, Barbara, Kloskowski, Tomasz, Zegarski, Wojciech, Drewa, Tomasz, Medina, Edward A., Zhao, Zhenze, Liang, Sitai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039383/
https://www.ncbi.nlm.nih.gov/pubmed/27698899
http://dx.doi.org/10.7150/jca.14747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039383/
https://www.ncbi.nlm.nih.gov/pubmed/27698899
http://dx.doi.org/10.7150/jca.14747

Ejemplares similares